Home Cart Sign in  
Chemical Structure| 2639957-39-2 Chemical Structure| 2639957-39-2

Structure of Exarafenib
CAS No.: 2639957-39-2

Chemical Structure| 2639957-39-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Exarafenib is a pan-RAF inhibitor that effectively suppresses the activity of RAF kinases, particularly BRAF mutants. It shows broad potential in targeted cancer therapy, especially with significant efficacy in BRAF mutation-driven tumors.

Synonyms: RAF/KIN_2787; KIN-002787; Exarafenib, RAF/KIN_2787

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Exarafenib

CAS No. :2639957-39-2
Formula : C26H34F3N5O3
M.W : 521.58
SMILES Code : O=C(N1C[C@H](CC(F)(F)F)CC1)NC2=CC=C(C)C(C3=CC(N[C@H](C)CO)=NC(N4CCOCC4)=C3)=C2
Synonyms :
RAF/KIN_2787; KIN-002787; Exarafenib, RAF/KIN_2787
MDL No. :N/A

Safety of Exarafenib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Exarafenib

MAPK
TLR

Isoform Comparison

Biological Activity

Description
Exarafenib (RAF/KIN_2787) is an oral, selective pan-RAF inhibitor effective against RAF-dependent cancers, covering all types of BRAF mutations. It inhibits MAPK signaling in RAF-dependent melanoma cell lines and exhibits anticancer properties[1][2].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.92mL

0.38mL

0.19mL

9.59mL

1.92mL

0.96mL

19.17mL

3.83mL

1.92mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories